• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
Jada system did not work for cesarean section patient due to blood clots.[device ineffective] provider concerning placement of jada system seal in the vagina and not the fundus [wrong technique in device usage process] no additional ae [no adverse event] case narrative: this spontaneous report originating from united states was received from a physician via clinical educator (ce), referring to a non-pregnant female patient of unknown age.The patient¿s historical condition included singleton pregnancy, c-section, gravida iii, para 1 and delivery.The patient¿s current conditions included blood clots.The patient's concomitant medications and past drug reactions/allergies were not reported.This report concerns 1 patient(s) and 1 device(s).On an unknown date, the patient underwent an insertion procedure with vacuum-induced hemorrhage control system (jada system) via intravaginal route (lot #, serial # and expiration date were not reported) for post-partum hemorrhage.On unknown date, the vacuum-induced hemorrhage control system (jada system) did not work for cesarean section patient due to blood clots (device ineffective).Provider reported patient had to have hysterectomy.Reporter denied any quality issues with vacuum-induced hemorrhage control system (jada system).Clinical educator provided information to provider concerning placement of vacuum-induced hemorrhage control system (jada system) seal in the vagina and not the fundus (wrong technique in device usage process).The vacuum-induced hemorrhage control system (jada system) did not control bleeding and worked without issue, but the bleeding continued worked without issues, but blood clots hampered device.Patient had not used more than one vacuum-induced hemorrhage control system (jada system).This was not the operator¿s first time using or first experience with device.The patient sought medical attention.No product quality complaint (pqc) reported.No additional adverse event (ae) (no adverse event or further information reported.Therapy with vacuum-induced hemorrhage control system (jada system) was discontinued.Upon internal review, the event device ineffective was determined to be serious due to required intervention (devices).When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.Medical device reporting criteria: serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key18998083
MDR Text Key338881420
Report Number3002806821-2024-00025
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-